Nca # 274090 09/25/2020 10:33:46
Total Page:16
File Type:pdf, Size:1020Kb
Northern Care Alliance (NCA) NHS Group Salford Royal NHS Foundation Trust (SRFT) The Group Board operates as a Committees in Common and conducts shared meeting of: Group Board (Salford) – established by Salford Royal NHS Foundation Trust; and Group Board (Oldham, Bury and Rochdale) – established by Pennine Acute Hospitals NHS Trust. Group Board Meeting Monday, 28th September 2020 From 10.00am via video-conferencing facility (Microsoft Teams) Agenda Part 1 – held in public 1. Opening Matters: 1.1 Patient Story Member of staff 1.2 Apologies for Absence Chairman 1.3 Declarations of Interest All 1.4 Chairman’s Opening Remarks Chairman 1.5 Minutes of Previous Meeting Chairman - minutes from discussion of non-confidential matters at the meeting on 27th July 2020 2. Matters for Decision 2.1 Constitution Group Secretary 2.2 Group Governance Framework Manual Group Secretary 3. Matters for Review/Discussion 3.1 Integrated Group Board Performance Scorecard - Executive Summary Chief Executive Officer - Care Organisation key risks/actions Care Organisation Chief Officers 3.2 Finance and Activity Report Chief Financial Officer 3.3 Infection Prevention and Control Report Chief Medical Officer 3.4 Harm Reduction: Safety Improvement Chief Nursing Officer 3.5 Learning from Deaths Update Chief Medical Officer - Including Oldham and Fairfield Reviews 3.6 Intentional Inclusion At the Heart of the Communities Chief of People We Serve: Our 10 Year Vision for Change 3.7 Social Value Update Chief of People 3.8 Seasonal Influenza Vaccination Programme Chief of People 3.9 Geoffrey Jefferson Institute for Brain Research ChiefNCA Medical # 274090 Director 09/25/2020 10:33:46 4. Matters for Noting 1/2 1/163 4.1 Chairman’s Report from Council of Governors Chairman - meeting on 23 September 2020 4.2 Audit Committee Chairman of Audit Committee - meeting on 30 July and 24 September 2020 4.3 Group Executive Risk and Assurance Committee Chief Executive - meetings held 24 August & 21 September 2019 4.4 Report from Charitable Funds Committee Chairman of Charitable Funds - meeting held on 6 August and 3 September 2020 Committee 5. Closing Matters 5.1 Any Other Business All 5.2 Date and Time of Next Meeting: Chairman Monday, 26th October 2020 from 10am Via video conference facility. 5.3 Resolution: Chairman To exclude the press and public from the meeting at this point on the grounds that publicity of the matters being reviewed would be prejudicial to public interest, by reason of the confidential nature of business. The press and public are requested to leave at this point. Close. NCA # 274090 09/25/2020 10:33:46 2/2 2/163 The Northern Care Alliance NHS Group Salford Royal NHS Foundation Trust (SRFT) The Group Board operates as a Committees in Common and conducts shared meeting of: Group Board (Salford) – established by Salford Royal NHS Foundation Trust; and Group Board (Oldham, Bury and Rochdale) – established by Pennine Acute Hospitals NHS Trust. Shared Agenda Group Board (Committees in Common) Monday, 27 July 2020 at 10:00am Via video-conferencing facility (Microsoft Teams) Part 1 - held in public Present: Mr Jim Potter, Chairman Mr Raj Jain, Chief Executive Officer Mrs Judith Adams, Chief Delivery Officer Mr Chris Brookes, Chief Medical Officer Ms Nicky Clarke, Chief People Officer Mr Kieran Charleson, Non-Executive Director Mr Tim Crowley, Non-Executive Director Mrs Carmen Drinkwater, Non-Executive Director Mr Simon Featherstone, Interim Chief Officer/Director of Nursing, Bury Care Organisation Mrs Nicola Firth, Director of Nursing/Chief Officer Oldham Care Organisation Mrs Elaine Inglesby-Burke CBE, Chief Nursing Officer Mrs Christine Mayer CBE, Non-Executive Director/Vice Chairman Mr Ian Moston, Chief Finance Officer Professor Chris Reilly, Senior Independent Director Mr Jack Sharp, Chief Strategy Officer Mr Peter Turkington, Medical Director/Chief Officer Salford Care Organisation Mr Steve Taylor, Director of Operations/Chief Officer Bury & Rochdale Care Organisation Mrs Jane Burns, Director of Corporate Services and Group Secretary Mrs Rebecca McCarthy, Deputy Group Secretary Apologies for Absence: Dr Hamish Stedman, Non-Executive Director Welcome The Chairman welcomed everyone present to the meeting of the Group Board (Committees in Common). The Chairman confirmed that the meeting would be held in two parts: a first part open to members of the public; and a second part in private session for confidential matters. 1. Opening Matters: 1.1 Patient Stories The Group Board (Committees in Common) watched a presentation highlighting the stories of patients whose care had been disrupted NCAby the # 274090 Covid-19 crisis. 09/25/2020 10:33:46 1.2 Apologies for Absence 1/13 3/163 Apologies for absence were noted as above. 1.3 Declarations of Interest The Chairman requested that officers declared any actual or potential conflict of interest relevant to their role as a member of the Group Board (Committees in Common) and in particular to any matter being discussed at the meeting. There were no interests declared. 1.4 Chairman’s Opening Remarks Holding Board Meetings in Public The Chairman confirmed that due to the government’s current social distancing rules and guidance from NHS Improvement/England (NHSIE), it was not possible to hold face to face meetings of the Board in public, with Board meetings currently taking place in private via videoconferencing facility. The Chairman stated that throughout the pandemic, all non-confidential papers and summaries of the Board’s non-confidential minutes had been made available publicly, with Board agendas and minutes shared with governors throughout, via the Governor Portal, alongside a Chair’s Feedback to governors after each Board meeting. The Chairman confirmed the meeting today, was arranged in two parts: o Part 1 - All non-confidential matters, and o Part 2 - All confidential matters. The Chairman stated that the Part 1 agenda, papers and minutes were available to the public via the websites. The Chairman concluded that, from September 2020, the Board would have arrangements in place for members of the public (and staff) to register to observe the meeting, as it is happening, via MS Teams, and that this would be communicated to staff and the public via the website. Arrangements - Non-Executive Directors The Chairman confirmed that arrangements were being made for all non- executive directors to connect informally with each of the Care Organisation leadership teams, with similar opportunity with the leadership teams of Diagnostics & Pharmacy, Estates and Facilities, Digital and other corporate functions. Professor of Nursing The Chairman confirmed the Northern Care Alliance NHS Group (NCA) had developed a proposal with the University of Salford for a Professor of Nursing position, and confirmed that this position had now been established and appointed to. The Chief Nursing Officer confirmed the appointment of Professor Heather Iles-Smith and provided a brief summary of Professor Iles- Smith’s experience. 1.5 Minutes of Previous Meeting The minutes from discussion of non-confidential matters at the meeting on 29th June 2020 were reviewed by the Group Board (Committees in Common) and approved as a true record. NCA # 274090 2. Matters for Decision: 09/25/2020 10:33:46 2.1 Group Board Assurance Framework 2020/21 2/13 4/163 The Chief Executive Officer presented a paper describing the transition from the interim Group Board Assurance Framework, detailing significant high-level risks against the delivery of the interim objectives, to the current Group Board Assurance Framework (BAF) 2020/21 as presented. He confirmed that the Group Board had approved the NCA’s strategic priorities and principal objectives and deliverables for 2020/21 at its meeting in June 2020, and presented the principal risks to the delivery of these objectives, along with controls, assurances and required actions. The Chief Executive Officer confirmed that the newly created Group BAF reflected the updated position of the previous interim principal risks and reassessment of the principal risks identified prior to the pandemic (2019/20). The Chief Executive Officer confirmed that, in line with the NCA’s principal objectives, the Care Organisations and the Group Diagnostics & Pharmacy (D&P) Business Unit had established their objectives for 2020/21, and from this developed their BAFs. He added that the most significant risks (scored at 12 and above) identified by the Care Organisations and D&P had been aligned to the Group’s principal risks, influenced the risk assessments that had taken place at Group-level, and incorporated explicitly within the Group BAF. The Chief Executive Officer confirmed that the NCA’s current risk appetite was stated within the Group BAF, and expressed his view that further development, in light of the current context, may be valuable for the Group Board. A Non- Executive Director welcomed the opportunity for further debate with respect to risk appetite. Additionally, the Non-Executive Director sought further information with respect to the Infection Prevention Control (IPC) risk, specifically seeking view on a target risk score of 12 (significant risk), albeit the NCA’s risk appetite was to not tolerate risks to patient safety. The Chief Medical Officer acknowledged this comment, highlighting the suite of measures, controls and assurances in place with respect to IPC, as recognised as compliant via the CQC. The Chief Medical Officer expressed his view that further assurance with respect to the reliability of measures in place was required, therefore the current risk was scored as 13, with a target risk score of 12 by the end of September 2020, in light of the need to ensure reliability throughout the suite of measures beyond this. The Senior Independent Director highlighted inconsistency in the risk score related to medical education between the summary paper and Group BAF. The Group Secretary confirmed consistency in scoring would be corrected. The Chairman concluded the discussion, further highlighting the value of Chief Group Board exploring risk appetite with respect to the Group BAF.